Literature DB >> 22687548

Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial.

Richard S E Keefe1, Sophia Vinogradov, Alice Medalia, Peter F Buckley, Stanley N Caroff, Deepak C D'Souza, Phillip D Harvey, Karen A Graham, Robert M Hamer, Stephen M Marder, Del D Miller, Stephen J Olson, Jayendra K Patel, Dawn Velligan, Trina M Walker, Adam J Haim, T Scott Stroup.   

Abstract

BACKGROUND: The true benefit of pharmacologic intervention to improve cognition in schizophrenia may not be evident without regular cognitive enrichment. Clinical trials assessing the neurocognitive effects of new medications may require engagement in cognitive remediation exercises to stimulate the benefit potential. However, the feasibility of large-scale multisite studies using cognitive remediation at clinical trials sites has not been established.
METHOD: 53 adult patients with DSM-IV schizophrenia from 9 university-affiliated sites were randomized to a cognitive remediation condition that included the Posit Science Brain Fitness auditory training program with weekly Neuropsychological and Educational Approach to Remediation (NEAR) "bridging groups" or a control condition of computer games and weekly healthy lifestyles groups. Patients were expected to complete 3 to 5 one-hour sessions weekly for 40 sessions or 12 weeks, whichever came first. The primary outcomes were feasibility results as measured by rate of enrollment, retention, and completion rate of primary outcome measures. The study was conducted from July 2009 through January 2010.
RESULTS: During a 3-month enrollment period, 53 (of a projected 54) patients were enrolled, and 41 (77%) met criteria for study completion. Thirty-one patients completed all 40 sessions, and all patients completed all primary outcome measures. Preliminary efficacy results indicated that, after 20 sessions, patients in the cognitive remediation condition demonstrated mean MATRICS Consensus Cognitive Battery composite score improvements that were 3.7 (95% CI, 0.05-7.34) T-score points greater than in patients in the computer-games control group (F(1,46) = 4.16, P = .047). At the end of treatment, a trend favoring cognitive remediation was not statistically significant (F(1,47) = 2.26, P = .14).
CONCLUSION: Multisite clinical trials of cognitive remediation using the Posit Science Brain Fitness auditory training program with the NEAR method of weekly bridging groups at traditional clinical sites appear to be feasible. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00930150. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22687548      PMCID: PMC3746329          DOI: 10.4088/JCP.11m07100

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  33 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Cognitive remediation therapy needs funding.

Authors:  Til Wykes
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  Defining a cognitive function decrement in schizophrenia.

Authors:  Richard S E Keefe; Charles E Eesley; Margaret P Poe
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

4.  Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later.

Authors:  Melissa Fisher; Christine Holland; Karuna Subramaniam; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

5.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

6.  Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?

Authors:  Nicholas Tarrier; Til Wykes
Journal:  Behav Res Ther       Date:  2004-12

7.  What predicts a good response to cognitive remediation interventions?

Authors:  Alice Medalia; Randall Richardson
Journal:  Schizophr Bull       Date:  2005-08-24       Impact factor: 9.306

8.  Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial.

Authors:  Susan R McGurk; Kim T Mueser; Karin Feldman; Rosemarie Wolfe; Alysia Pascaris
Journal:  Am J Psychiatry       Date:  2007-03       Impact factor: 18.112

Review 9.  Behavioral therapy for weight loss in patients with schizophrenia.

Authors:  Rohan Ganguli
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  33 in total

1.  Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial.

Authors:  Henry W Mahncke; Sarah-Jane Kim; Annika Rose; Catherine Stasio; Peter Buckley; Stanley Caroff; Erica Duncan; Sarah Yasmin; L Fredrik Jarskog; J Steven Lamberti; Keith Nuechterlein; Martin Strassnig; Dawn Velligan; Joseph Ventura; Trina Walker; T Scott Stroup; Richard S E Keefe
Journal:  Schizophr Res       Date:  2019-03-28       Impact factor: 4.939

2.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

3.  Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia.

Authors:  Melissa Fisher; Rachel Loewy; Cameron Carter; Ashley Lee; J Daniel Ragland; Tara Niendam; Danielle Schlosser; Lien Pham; Tara Miskovich; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2014-01-20       Impact factor: 9.306

4.  Motivational Interviewing to Increase Cognitive Rehabilitation Adherence in Schizophrenia.

Authors:  Joanna M Fiszdon; Matthew M Kurtz; Jimmy Choi; Morris D Bell; Steve Martino
Journal:  Schizophr Bull       Date:  2015-09-29       Impact factor: 9.306

Review 5.  Cognitive training for impaired neural systems in neuropsychiatric illness.

Authors:  Sophia Vinogradov; Melissa Fisher; Etienne de Villers-Sidani
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

6.  Computer-assisted cognitive remediation for schizophrenia: a randomized single-blind pilot study.

Authors:  Olga Rass; Jennifer K Forsyth; Amanda R Bolbecker; William P Hetrick; Alan Breier; Paul H Lysaker; Brian F O'Donnell
Journal:  Schizophr Res       Date:  2012-06-09       Impact factor: 4.939

7.  d-Cycloserine augmentation of cognitive remediation in schizophrenia.

Authors:  Christopher K Cain; Margaret McCue; Iruma Bello; Timothy Creedon; Dei-In Tang; Eugene Laska; Donald C Goff
Journal:  Schizophr Res       Date:  2014-01-30       Impact factor: 4.939

8.  Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia.

Authors:  Melissa Tarasenko; Veronica B Perez; Sean T Pianka; Sophia Vinogradov; David L Braff; Neal R Swerdlow; Gregory A Light
Journal:  Schizophr Res       Date:  2016-02-02       Impact factor: 4.939

9.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

10.  Engagement with the auditory processing system during targeted auditory cognitive training mediates changes in cognitive outcomes in individuals with schizophrenia.

Authors:  Bruno Biagianti; Melissa Fisher; Torsten B Neilands; Rachel Loewy; Sophia Vinogradov
Journal:  Neuropsychology       Date:  2016-09-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.